Further analysis showed that loss of AIM2 expression in HCC tissues was significantly correlated with later TNM stages, larger tumor volumes and more advanced metastasis status (*P < 0.05, Figure 1D–1F). The gene discussed is AIM2; the disease is hepatocellular carcinoma.